No patients have been signed up to receive treatment under Ireland’s medicinal cannabis programme in the four months since the scheme opened for registration.
Dr Colin Doherty, a consultant neurologist and director of the epilepsy service at St James’s Hospital, Dublin, said that the health department and epileptologists had been “working at cross-purposes” in attempting to make a cannabis-based medicine available.
The HSE said the supplier of one cannabis-based medicinal product, CannEpil, had confirmed that the drug was readily available for supply to pharmacies since last month. Medical consultants have been able to register patients for treatment under the medical cannabis access programme (MCAP) since July.
However, the HSE said there had not yet been any engagement with the programme from clinicians. “As yet, the